Research and Markets: China Contrast Media (Contrast Agent) Market, 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/tj8m5b/research_and) has announced the addition of the "Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2014" report to their offering.

With the mushroom growth of world diagnostic imaging equipments and apparatuses, as for X-CT contrast media, iodinated contrast media serving as the main one is witnessing unprecedented development. Iohexol is featured with great security, high contrast ratio, lower osmotic pressure and small toxicity for human bodies etc. has become the best-selling contrast media in international market. The sales amount of all kinds of contrast media across the world has exceeded USD 23 billion in 2013, with growth continued to rise at the rate of 6% to 8%.

In recent two years, as for the drug procurement in 22 cities in China, there were six major varieties of contrast media, namely, iohexol, iopromide, gadopentetate dimeglumine, iopamidol, ioversol and meglumine diatrizoate, of which the former three varieties were listed among the best-selling 200 drugs. Recently, hospitals attached more importance to instrument testing, boosting the development of contrast media market.

According to the procurement of contrast media from sampled hospitals in 16 cities, iohexol and iopromide rank first and second respectively, accounting for 43% and 32% of market shares of CT contrast media respectively in domestic market. As for domestic MRI contrast media, gadopentetate dimeglumine still plays the leading role, accounting for 83% of market shares of MRI contrast media.

Key Topics Covered

1. Development Overview of Contrast Media Industry

1.1 Overview of Industry

1.2 Industry China

2. Development Overview of Global Contrast Media Industry

2.1 Development Status

2.2 Application for International Contrast Media Patents

3. Environment Analysis of China's Contrast Media Industry

3.1 China's Economic Development Environment

3.2 Policy Environment

3.3 Domestic Technological Level of Contrast Media

4. Analysis on China's Contrast Media Industry

4.1 Domestic Market Status and Forecast

4.2 Segment Products

4.3 Factors Affecting Contrast Media Development

5. Competitive Landscape of China's Contrast Media Industry

5.1 Competitiveness Analysis

5.2 Concentration Ratio of Contrast Media Industry

6. Import and Export Data of Contrast Media Products

6.1 Import and Export Data of X-Ray Contrast Media and Diagnostic Reagent, 2010-2013

6.2 Import Sources and Export Destinations of X-Ray Contrast Media and Diagnostic Reagent, 2013

7. Domestic Major Contrast Media Manufacturing Enterprises

8. Investment and Development Trend of Contrast Media Industry

8.1 Investment Opportunities

8.2 Investment Risks

8.3 Development Trend of China's Contrast Media Industry

8.4 Suggestions

Companies Mentioned

- Yangtze River Pharmaceutical

- BEILU Pharmaceutical

- Jiangsu Hengrui Medicine

- China Resources Double-crane Pharmaceutical

- Shanghai Xudong Haipu Pharmaceutical

For more information visit http://www.researchandmarkets.com/research/tj8m5b/research_and

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics